Prospective evaluation of screening infertile women using clomiphene citrate challenge test in tertiary care centre of Chengalpattu, Tamil Nadu

Aneesha Raj; C. Santhanalakshmi

doi:10.18203/2320-1770.ijrcog20242292

Authors

Aneesha Raj Department of Obstetrics and Gynecology, Karpaga Vinayaga Institute of Medical Science, Tamil Nadu, India
C. Santhanalakshmi Department of Obstetrics and Gynecology, Karpaga Vinayaga Institute of Medical Science, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20242292

Keywords:

Clomiphene citrate challenge test, Fertility, FSH level, Infertility prevalence, Ovarian reserve

Abstract

Background: The clomiphene citrate challenge test is a sensitive tool for predicting the ovarian reserve and fertility. Thus, we studied the ovarian reserve in infertile patients using the clomiphene citrate challenge test to analyse the outcomes of the study (pregnancy).

Methods: This study included 30 patients with OPD from the Department of Obstetrics and Gynecology at Karpaga Vinayaga Medical College. The study used an Esaote ultrasound machine (Model MyLabSix) as the primary instrument. Infertile women were screened using the Clomiphene Citrate Challenge Test.

Results: In 30 patients undergoing a prospective evaluation using the clomiphene citrate challenge test, the mean age was 31.27±2.38 years, with a BMI of 23.89±3.11. The average duration of infertility was 6.30±2.15 years. Primary infertility was observed in 90.0% (27/30) of participants, while 13.3% (4/30) had secondary infertility. Menstrual irregularities included regular cycles (43.3%), irregular cycles (46.7%), heavy bleeding (10.0%), and dysmenorrhea (3.3%). Urine pregnancy test results indicated 60.0% negative and 40.0% positive outcomes. Hormonal assessments showed similar cycle day 3 estradiol levels (p = 0.578), cycle day 3 FSH levels (p = 0.236), cycle day 10 FSH levels (p = 0.933), and antral follicle counts (p = 0.99) between primary and secondary infertility groups. Additionally, there was no significant difference in the distribution of infertility types by UPT result (p = 0.661).

Conclusions: The findings of this study highlight the significance of assessing the ovarian reserve as a crucial factor in predicting pregnancy outcomes. Understanding the ovarian reserve aids clinicians in tailoring personalised treatment strategies for infertility management.

Metrics

Metrics Loading ...

References

Wu JM, Takahashi DL, Ingram DK, Mattison JA, Roth G, Ottinger MA, et al. Ovarian reserve tests and their utility in predicting response to controlled ovarian stimulation in rhesus monkeys. Am J Primatol 2010;72(8):672-80.

Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem 2018;62:2-10.

Carson SA, Kallen AN. Diagnosis and management of infertility: A review. JAMA 2021;326(1):65.

Sharma N, Chakrabarti S, Sharma N, Chakrabarti S. Ovarian Reserve. In: Innovations In Assisted Reproduction Technology IntechOpen; 2019.

Brown J, Farquhar C. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochr Libr. 2016;2017.

Ulrich ND, Marsh EE. Ovarian reserve testing: A review of the options, their applications, and their limitations. Clin Obstet Gynecol. 2019;62(2):228-37.

In Vitro Fertilization. HRC Fertility. Available at: https://www.havingbabies.com/in-vitro-fertilization/. Accessed 01 March 2024.

Adamson PC, Krupp K, Freeman AH, Klausner JD, Reingold AL, Madhivanan P. Prevalence & correlates of primary infertility among young women in Mysore, India. Indian J Med Res. 2011;134(4):440-6.

Baby A, Varghese AA, Jose C, Kandasamy K, Rajagopal SS. A prospective evaluation of causes and treatment of infertility in a tertiary care hospital, Erode. Asian J Pharm Clin Res 2018;11(2):149-53.

Magendzo A, Schwarze J-E, de la Vega CD, Altieri E, Zegers-Hochschild F, Balmaceda JP. Clomiphene citrate challenge test predicts outcome of intrauterine insemination in women aged under 37 years. Reprod Biomed Online. 2006;12(4):423-7.

Csemiczky G, Harlin J, Fried G. Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment. Acta Obstet Gynecol Scand. 2002;81(10):954-61.

Jain T, Soules MR, Collins JA. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril. 2004;82(1):180-5.

Yanushpolsky EH, Hurwitz S, Tikh E, Racowsky C. Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in women younger than 40 years of age. Fertil Steril. 2003;80(1):111-5.